首页 | 本学科首页   官方微博 | 高级检索  
检索        

石杉碱甲胶囊和片剂治疗阿尔采末病的多中心双盲研究
引用本文:陈美娟,高之旭,邓红玉,刘福根,马永兴,余慧贞,黄流清,翁正.石杉碱甲胶囊和片剂治疗阿尔采末病的多中心双盲研究[J].中国新药与临床杂志,2000,19(1):10-12.
作者姓名:陈美娟  高之旭  邓红玉  刘福根  马永兴  余慧贞  黄流清  翁正
作者单位:1. 上海市精神卫生中心,上海,200030
2. 华东医院,上海,200040
3. 上海第二医科大学,附属瑞金医院,上海,200025
4. 中国人民解放军第二军医大学,附属长征医院,上海,200003
5. 山东省精神卫生中心,山东,济南,250014
摘    要:目的:比较石杉碱甲胶囊和片剂治疗轻中度阿尔采末病(AD)的疗效和不良反应。方法:92例AD病人随机分2组,胶囊组55例(男性27例,女性 28例,年龄 69 a ± s7 a);片剂组 37例(男性17例,女性 20例,年龄 71a± 6a)。给石杉碱甲胶囊或片剂 0. 15 mg,po, bid × 8 wk。结果:胶囊组和片剂组总有效率分别为 69%, 57%,2组比较差异无显著意义(P>0.05)。结论:石杉碱甲是一个安全、有效的治疗AD药物,肢囊剂型与片剂剂型疗效相似。

关 键 词:石杉碱甲  胶囊  片剂  阿尔采末病  双盲法  多中心研究
文章编号:1007-7669(2000)01-0010-03

Huperzine A capsules vs tablets in treatment of Alzheimer disease: multicenter studies
CHEN Mei-Juan,GAO Zhi-Xu,DENG Hong-Yu,LIU Fu-Gen,MA Yong-Xing,YU Hui-Zhen,HUANG Liu-Qing,WENG Zheng.Huperzine A capsules vs tablets in treatment of Alzheimer disease: multicenter studies[J].Chinese Journal of New Drugs and Clinical Remedies,2000,19(1):10-12.
Authors:CHEN Mei-Juan  GAO Zhi-Xu  DENG Hong-Yu  LIU Fu-Gen  MA Yong-Xing  YU Hui-Zhen  HUANG Liu-Qing  WENG Zheng
Abstract:AIM: To compare the clinical efficacies and adverse reactions of huperzine A capsules and tablets in treating Alzheimer disease(AD). METHODS: Ninety-two patients with mild to moderate AD were recruited. Fifty-five patients (M 27, F 28; age 69 a ± s 7 a) were treated with huperzine A capsule, 0. 15 mg,po, bid for & wk and 37 patients (M 17, F 20; age 71 a± 6 a) were treated with huperzine A tablet, 0. 15 mg, po, bid for 8 wk. RESULT: The clinical efficacy was 69% in the huperzine A capsule group and 57% in the huperzine A tablet group (P > 0. 05 ). CONCLUSION: Huperzine A capsules is similar to huperzine A tablets in treating mild to mederate AD patients.
Keywords:Huperzine A  capsules  tablets  Alzheimer disease  double-blind method  multicenter studies
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号